⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 1, 1955American Journal of Clinical Pathology

Inhibition of Conversion of Fibrinogen to Fibrin by Abnormal Proteins in Multiple Myeloma

View at Publisher

Ask AI

Bookmark

Share

Abstract

Paul G. Frick, M.D.; Inhibition of Conversion of Fibrinogen to Fibrin by Abnormal Proteins in Multiple Myeloma, American Journal of Clinical Pathology, Volume 2

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

P Frick (1955) studied this question.

synapsesocial.com/papers/6a92654738cfebe1d7384763 https://doi.org/10.1093/ajcp/25.11.1263

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1BRAF V600E–mutated marginal zone lymphoma may exhibit features that partially overlap with hairy cell leukemiaAmerican Journal of Clinical Pathology · 2026
2Preanalytical variables in surgical pathology: practical sources of diagnostic error before microscopic interpretationAmerican Journal of Clinical Pathology · 2026
3Risk factors for lymph node metastasis in a contemporary radical prostatectomy cohortAmerican Journal of Clinical Pathology · 2026
4How I diagnose Erdheim-Chester diseaseAmerican Journal of Clinical Pathology · 2026
5Optimizing diagnostic utility for diagnosis and management of Helicobacter pylori infections through combined microbiology and pathology approaches: a 7-year studyAmerican Journal of Clinical Pathology · 2026

Single-cohort next-generation sequencing analysis of 713 anaplastic thyroid carcinomas: unreported gene alterations and actionable targetsAmerican Journal of Clinical Pathology · 2026
Evaluation of a virulence gene repertoire as a means to investigate the role in the causal pathway to death of Escherichia coli isolated from postmortem specimens, northern TanzaniaAmerican Journal of Clinical Pathology · 2026
Measurement of hemolysis in packed red blood cell segments and units using H indexAmerican Journal of Clinical Pathology · 2026
Optical genome mapping refines diagnosis of high-grade myeloid neoplasms through detection of MECOM rearrangements cryptic to conventional karyotypeAmerican Journal of Clinical Pathology · 2026
The essentials—measurable residual disease in hematopoietic neoplasms: current testing landscape and future directionsAmerican Journal of Clinical Pathology · 2026

More from American Journal of Clinical Pathology

More from University of Minnesota Medical Center